Article
Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches.
Journal of biomolecular structure & dynamics - 1 Jun 2017
Farasat Alireza, Rahbarizadeh Fatemeh, Hosseinzadeh Ghader, Sajjadi Sharareh, Kamali Mehdi, Keihan Amir Homayoun
Abstract excerpt
Epidermal growth factor receptor (EGFR), a transmembrane glycoprotein, is overexpressed in many cancers such as head-neck, breast, prostate, and skin cancers for this reason it is a good target in cancer therapy and diagnosis. In nanobody-based cancer diagnosis and treatment, nanobodies with high affinity toward receptor (e.g. EGFR) results in effective treatment or diagnosis of cancer. In this regard, the main...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
